HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C A M Fraga Selected Research

LASSBio-881

4/2010LASSBio-881: an N-acylhydrazone transient receptor potential vanilloid subfamily type 1 antagonist orally effective against the hypernociception induced by capsaicin or partial sciatic ligation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C A M Fraga Research Topics

Disease

1Sleep Initiation and Maintenance Disorders (Insomnia)
03/2013
1Body Weight (Weight, Body)
05/2010
1Hyperthermia
04/2010
1Sciatic Neuropathy (Lesion of Sciatic Nerve)
04/2010
1Pain (Aches)
04/2010
1Catalepsy
05/2003
1Parkinson Disease (Parkinson's Disease)
05/2003
1Schizophrenia (Dementia Praecox)
05/2003
1Inflammation (Inflammations)
04/2002

Drug/Important Bio-Agent (IBA)

1megazolIBA
05/2010
1Cannabinoid Receptors (Cannabinoid Receptor)IBA
04/2010
1LASSBio-881IBA
04/2010
1Dopamine (Intropin)FDA LinkGeneric
05/2003
1Amphetamine (Amfetamine)FDA LinkGeneric
05/2003
1ApomorphineFDA Link
05/2003
1CatecholaminesIBA
05/2003
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
04/2002

Therapy/Procedure

2Oral Administration
05/2010 - 04/2010
1General Anesthesia
03/2013
1Ligation
04/2010
1Induced Hypothermia
05/2003